KUKJEON PHARMACEUTICAL Statistics

Total Valuation

KUKJEON PHARMACEUTICAL has a market cap or net worth of KRW 170.02 billion. The enterprise value is 176.10 billion.

Market Cap	170.02B
Enterprise Value	176.10B

Important Dates

The next estimated earnings date is Thursday, February 27, 2025.

Earnings Date	Feb 27, 2025
Ex-Dividend Date	n/a

Share Statistics

KUKJEON PHARMACEUTICAL has 49.07 million shares outstanding. The number of shares has decreased by -4.23% in one year.

Current Share Class	n/a
Shares Outstanding	49.07M
Shares Change (YoY)	-4.23%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	62.00%
Owned by Institutions (%)	0.16%
Float	18.65M

Valuation Ratios

The trailing PE ratio is 25.85.

PE Ratio	25.85
Forward PE	n/a
PS Ratio	1.26
PB Ratio	1.71
P/TBV Ratio	1.74
P/FCF Ratio	55.10
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 25.90, with an EV/FCF ratio of 57.07.

EV / Earnings	26.72
EV / Sales	1.31
EV / EBITDA	25.90
EV / EBIT	92.48
EV / FCF	57.07

Financial Position

The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.77.

Current Ratio	1.17
Quick Ratio	0.93
Debt / Equity	0.77
Debt / EBITDA	11.24
Debt / FCF	24.96
Interest Coverage	0.24

Financial Efficiency

Return on equity (ROE) is 5.82% and return on invested capital (ROIC) is 0.72%.

Return on Equity (ROE)	5.82%
Return on Assets (ROA)	0.54%
Return on Capital (ROIC)	0.72%
Revenue Per Employee	777.11M
Profits Per Employee	38.10M
Employee Count	173
Asset Turnover	0.59
Inventory Turnover	4.28

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -42.26% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-42.26%
50-Day Moving Average	3,909.70
200-Day Moving Average	4,951.80
Relative Strength Index (RSI)	40.30
Average Volume (20 Days)	121,956

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KUKJEON PHARMACEUTICAL had revenue of KRW 134.44 billion and earned 6.59 billion in profits. Earnings per share was 134.02.

Revenue	134.44B
Gross Profit	22.49B
Operating Income	1.95B
Pretax Income	4.34B
Net Income	6.59B
EBITDA	6.85B
EBIT	1.95B
Earnings Per Share (EPS)	134.02

Full Income Statement

Balance Sheet

The company has 71.33 billion in cash and 77.01 billion in debt, giving a net cash position of -5.68 billion or -115.71 per share.

Cash & Cash Equivalents	71.33B
Total Debt	77.01B
Net Cash	-5.68B
Net Cash Per Share	-115.71
Equity (Book Value)	99.55B
Book Value Per Share	2,020.51
Working Capital	18.42B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 12.60 billion and capital expenditures -9.52 billion, giving a free cash flow of 3.09 billion.

Operating Cash Flow	12.60B
Capital Expenditures	-9.52B
Free Cash Flow	3.09B
FCF Per Share	62.89

Full Cash Flow Statement

Margins

Gross margin is 16.73%, with operating and profit margins of 1.45% and 4.90%.

Gross Margin	16.73%
Operating Margin	1.45%
Pretax Margin	3.23%
Profit Margin	4.90%
EBITDA Margin	5.10%
EBIT Margin	1.45%
FCF Margin	2.30%

Dividends & Yields

This stock pays an annual dividend of 10.00, which amounts to a dividend yield of 0.29%.

Dividend Per Share	10.00
Dividend Yield	0.29%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	7.44%
Buyback Yield	4.23%
Shareholder Yield	4.52%
Earnings Yield	3.87%
FCF Yield	1.81%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KUKJEON PHARMACEUTICAL has an Altman Z-Score of 2.11. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.11
Piotroski F-Score	n/a